Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

IgG3 anticorps (AA 312-324) (HRP)

L’anticorps Lapin Polyclonal anti-IgG3 a été validé pour ELISA. Il convient pour détecter IgG3 dans des échantillons de Humain.
N° du produit ABIN7139886

Aperçu rapide pour IgG3 anticorps (AA 312-324) (HRP) (ABIN7139886)

Antigène

Voir toutes IgG3 Anticorps
IgG3

Reactivité

Humain

Hôte

  • 5
  • 1
Lapin

Clonalité

  • 4
  • 2
Polyclonal

Conjugué

  • 4
  • 1
  • 1
Cet anticorp IgG3 est conjugé à/à la HRP

Application

  • 4
  • 2
  • 1
ELISA
  • Épitope

    • 3
    • 1
    AA 312-324

    Fonction

    IGHG3 Antibody, HRP conjugated

    Purification

    Protein G purified

    Pureté

    >95 %

    Immunogène

    Peptide sequence from Human Immunoglobulin heavy constant gamma 3 protein (312-324AA)

    Isotype

    IgG
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène

    IgG3

    Autre désignation

    IGHG3

    Classe de substances

    Antibody

    Sujet

    Background: Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:22158414, PubMed:20176268). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed:17576170, PubMed:20176268).

    Aliases: IGHG3Immunoglobulin heavy constant gamma 3 antibody, HDC antibody, Heavy chain disease protein antibody, Ig gamma-3 chain C region antibody

    UniProt

    P01860
Vous êtes ici:
Chat with us!